Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01296516 · ClinicalTrials.gov registry record · NA
Postpartum Weight Loss and Exercise (PRIDE)
A NA study of Gestational Diabetes and Glucose Intolerance, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT01296516: Completed NA study of Gestational Diabetes and Glucose Intolerance, sponsored by Pennington Biomedical Research Center.
NCT01296516 is a NA study of Gestational Diabetes and Glucose Intolerance that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 7 participants, below the 322-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01296516, a NA study of Gestational Diabetes and Glucose Intolerance, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this pilot project is to test in 50 women with a history of gestational diabetes mellitus (GDM), the effectiveness and feasibility of an 8 month intensive lifestyle intervention to reduce the rate of metabolic abnormalities within 1 year after delivery.
Primary Outcome
To examine the incidence of glucose abnormalities (impaired fasting glucose, impaired glucose tolerance, type 2 diabetes) and health outcomes (changes in body fat, waist circumference and blood lipids)in women with a history of gestational diabetes, 12 months postpartum.
Conditions Studied
Interventions
- BEHAVIORAL Non-intervention group
- BEHAVIORAL Face to face
- BEHAVIORAL Telehelath Group
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2011-02 |
| Est. Completion | 2017-12 |
| Phase | NA |
What the finished NCT01296516 record still lists
NCT01296516 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 322-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Gestational Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Non-intervention group is the first listed.
NCT01296516 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT01296516 about?
NCT01296516 is a clinical study titled "Postpartum Weight Loss and Exercise (PRIDE)". The overall objective of this pilot project is to test in 50 women with a history of gestational diabetes mellitus (GDM), the effectiveness and feasibility of an 8 month intensive lifestyle intervention to reduce the rate of metabolic abnormalities within 1 year after delivery.
What is the current status of trial NCT01296516?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2011-02. Estimated completion is 2017-12.
What conditions does trial NCT01296516 study?
This clinical trial studies the following conditions: Gestational Diabetes, Glucose Intolerance.
What interventions are being tested in trial NCT01296516?
The interventions under investigation include: Non-intervention group (BEHAVIORAL), Face to face (BEHAVIORAL), Telehelath Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01296516?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01296516 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01296516's enrollment target sits among peer trials
7 42nd of 41 the lowest of 41 other Gestational Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia